Latest Articles
Lilly-backed Absci banks $100m to progress endometriosis, hair loss therapy - Pharmaceutical Technology
Lilly-backed Absci banks $100m to progress endometriosis, hair loss therapy Pharmaceutical Technology
Published: June 26, 2026, 10:33 a.m.
Fertility-Preserving Therapy May Impair Endometrial Function and IVF Success After Endometrial Cancer:... - Medical Dialogues
Fertility-Preserving Therapy May Impair Endometrial Function and IVF Success After Endometrial Cancer:... Medical Dialogues
Published: June 19, 2026, 2:30 p.m.
Immunotherapy in dMMR/MSI-H endometrial cancer – a true game-changer? - ESMO Daily Reporter
Immunotherapy in dMMR/MSI-H endometrial cancer – a true game-changer? ESMO Daily Reporter
Published: June 18, 2026, 2:24 p.m.
Antibody therapy points to a new treatment era for primary membranous nephropathy - Drug Discovery News
Antibody therapy points to a new treatment era for primary membranous nephropathy Drug Discovery News
Published: June 16, 2026, 9:19 p.m.
Antibody therapy points to a new treatment era for primary membranous nephropathy - drugdiscoverynews.com
Antibody therapy points to a new treatment era for primary membranous nephropathy drugdiscoverynews.com
Published: June 16, 2026, 9:19 p.m.
Jayne Kennedy’s Illness – The Endometriosis Battle That Stopped a Career in Its Tracks - privatetherapyclinics.co.uk
Jayne Kennedy’s Illness – The Endometriosis Battle That Stopped a Career in Its Tracks privatetherapyclinics.co.uk
Published: June 16, 2026, 1:01 a.m.
Menopause: Hormone therapy linked to 69% lower risk of thinning bones - Medical News Today
Menopause: Hormone therapy linked to 69% lower risk of thinning bones Medical News Today
Published: June 14, 2026, 7:46 p.m.
Cartherics secures Japanese patent to bolster cell therapy push - Biotech Dispatch
Cartherics secures Japanese patent to bolster cell therapy push Biotech Dispatch
Published: June 11, 2026, 1:50 a.m.
Cartherics secures Japanese patent to bolster cell therapy push - PharmaDispatch
Cartherics secures Japanese patent to bolster cell therapy push PharmaDispatch
Published: June 10, 2026, 12:17 a.m.
The RUBY trial: For certain patients, immunotherapy-chemo combination keeps advanced endometrial cancer from progressing for years - MSN
The RUBY trial: For certain patients, immunotherapy-chemo combination keeps advanced endometrial cancer from progressing for years MSN
Published: June 8, 2026, 8:37 p.m.
Link copied to clipboard!